
Lin Yuan: Gold has no value, and even a 50% pullback won't lead to positioning. It is not surprising that China Meheco's total market value will surpass that of the United States in the next 20 years

Lin Yuan shared his views on the gold and pharmaceutical markets before the Berkshire Hathaway shareholder meeting. He believes that in the next 20 years, the total market value of China's pharmaceuticals is expected to surpass that of the United States, and he stated that gold has no value and will not be invested in even if there is a pullback. He mentioned maintaining a certain cash reserve to seize market opportunities and believes that the renminbi interest rates will decline in the long term. Lin Yuan also analyzed Buffett's strategy of increasing cash, reflecting a defensive posture against the high valuations of U.S. stocks
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

